Omkar Pharmachem Limited has informed BSE Limited of a special window for the transfer and dematerialization (demat) of physical shares, pursuant to SEBI Circular No. HO/38/13/11/2026-MIRSD-POD/1/3750/2026 dated January 30, 2026. The company published newspaper advertisements — one in English and one in a vernacular language — to notify shareholders of this facility. The communication was signed by Managing Director Bhawani Shankar Goyal on May 14, 2026.

Special Window: Key Details

The special window is designed for shareholders holding physical securities whose transfer deeds were executed and sold or purchased prior to April 01, 2019. The window remains open from February 05, 2026 to February 04, 2027. Only requests accompanied by original share certificates, transfer deeds, and relevant supporting documents will be considered under this facility.

The following eligibility matrix outlines the conditions under which shareholders may lodge their physical securities:

Lock-In and Transfer Restrictions

Securities transferred under this special window shall be mandatorily credited to the transferee in demat mode only. Such securities will be placed under a lock-in period of one year from the date of registration of transfer. During this lock-in period, the securities shall not be transferred, lien-marked, or pledged.

Registrar and Share Transfer Agent Contact

Shareholders with queries regarding this special window are requested to contact the company's Registrar and Share Transfer Agents:

The notice was issued by order of the Board of Omkar Pharmachem Ltd., signed by Managing Director Bhawani Shankar Goyal (DIN: 03255904), dated May 13, 2026, from Ahmedabad.

Omkar Pharmachem Limited , a pharmaceutical company based in Ahmedabad, has announced significant developments following its recent board meeting. The company has appointed a new independent director and set the date for its upcoming Annual General Meeting (AGM).

Board Meeting Outcomes

The Board of Directors of Omkar Pharmachem Limited convened on August 27, 2025, and approved several key items:

1. 30th AGM Schedule: The company's 30th Annual General Meeting is scheduled for September 24, 2025, at 11:30 a.m. It will be held at Hotel Kanak, opposite Gujarat College, Ellisbridge, Ahmedabad.

2. New Independent Director: Mr. Anupam Kumar Mishra has been appointed as an Additional Non-executive Independent Director for a five-year term, effective August 27, 2025, subject to shareholder approval.

3. Material Related Party Transactions: The board approved material related party transactions, though specific details were not disclosed.

4. AGM Scrutinizer: M/s Maulik Bhavsar & Associates, a practicing company secretary firm, has been appointed as the scrutinizer for the AGM voting process for the financial year 2024-25.

5. Director's Report: The board approved the Director's report along with its annexures for the financial year ended March 31, 2025.

New Independent Director Profile

Mr. Anupam Kumar Mishra, aged 55, brings extensive experience in Management and Accountancy to Omkar Pharmachem's board. His appointment is based on the recommendation of the Nomination and Remuneration Committee and is subject to shareholder approval at the upcoming AGM.

Key details of Mr. Mishra's appointment include:

• Term: Five consecutive years, from August 27, 2025, to August 26, 2030
• Designation: Additional Director designated as Non-Executive Independent Director
• DIN: 03629083

The company has confirmed that Mr. Mishra has not been debarred from holding the office of a Director by any order passed by SEBI or any other such authority.

Additional Information

The board meeting commenced at 11:30 A.M. and concluded at 12:30 P.M. The company's management, led by Managing Director Bhawani Shankar Goyal, has submitted these details to the BSE Limited in compliance with SEBI regulations.

Omkar Pharmachem Limited continues to demonstrate its commitment to corporate governance through these appointments and disclosures. Shareholders and interested parties can look forward to more details at the upcoming AGM in September.